Studying the Effectiveness of Early Invasive Treatment in Elderly Patients With High-risk Non-ST-segment Elevation Acute Coronary Syndrome.

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60+
SponsorGia Dinh People Hospital

About this trial

The goal of this is observational study is to compare about MACE events and predisposing factors related to MACE events in elderly patients with high-risk non-ST acute coronary syndromes receiving early versus late invasive treatment . This study will anwser two questions.

Question 1: What will factors associate with implementing a late invasive strategy in elderly patients with high-risk non-ST-segment elevation acute coronary syndrome ? Question 2: Is a meaningful difference about mortality and complication rates as re-myocardial infarction, heart failure, re-hospitalization, stroke after 12 months between two groups of patients undergoing early invasive and late invasive strategies in elderly patients with in high-risk non-ST-segment elevation acute coronary syndrome?

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

aged 60 years and older

high - risk non-ST-segment elevation acute coronary syndrome (according to the 2023 European Heart Association recommended standards).

receives reperfusion intervention.

Disqualifiers

Acute coronary syndrome due to stent thrombosis, or coronary artery bypass graft occlusion.

Incomplete medical records.

Trial population

All patients aged 60 years and older were diagnosed with non-ST elevation acute coronary syndrome. Diagnosed with high-risk acute non-ST elevation syndrome and treated at Gia Dinh People's Hospital, Thong Nhat Hospital during the study period.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

385 Participants
are grouped into 2 trial groups
Group A: Observe the patient with early percutaneous coronary intervention
Group B: Observe the patient with late percutaneous coronary intervention

Trial outcomes

Primary outcomes

1

In-hospital death

recorded when death occurs during treatment or is confirmed by in-hospital monitoring

Time frame
one month

Secondary outcomes

1

after 12 months death

determined by the patient follow-up period from hospital discharge until results were recorded

Time frame
one year
2

MACE after 12 months include re-admission, recurrent myocardial infarction , stroke, heart failure

recorded

Time frame
one year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.